ImmunoVaccine Inc.

Thema bewerten
Beiträge: 3
Zugriffe: 2.271 / Heute: 1
IMMUNOVACCINE. kein aktueller Kurs verfügbar
 
iwanooze:

ImmunoVaccine Inc.

 
28.01.15 14:57

Werbung

Entdecke die beliebtesten ETFs von SPDR

SPDR MSCI World Utilities UCITS ETF
Perf. 12M: +21,33%
SPDR MSCI Europe Utilities UCITS ETF
Perf. 12M: +20,59%
SPDR MSCI Europe Financials UCITS ETF
Perf. 12M: +19,90%
SPDR MSCI Europe Communication Services UCITS ETF
Perf. 12M: +19,55%
SPDR S&P U.S. Utilities Select Sector UCITS ETF
Perf. 12M: +19,37%

iwanooze:

news dazu!

 
28.01.15 14:59
(0 Bewertungen)

Marketwired·Mehr Nachrichten von Marketwired
Immunovaccine Study Demonstrates Early Protection Against Anthrax with Single Dose Experimental Vaccines / Proprietary DepoVax Technology Works with Multiple rPA Antigens

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 01/28/15 -- Immunovaccine Inc. ("Immunovaccine") (TSX: IMV), a clinical stage vaccine and immunotherapy company, today announced that three different recombinant protective antigen (rPA) vaccines formulated with its novel DepoVaxâ„¢ enhancement technology protected animals against a lethal anthrax challenge after a single vaccination. The National Institutes of Health (NIH) led study demonstrates the potential of DepoVax as a universal enabler of single dose rPA-based anthrax vaccines.

The anthrax challenge study was designed to evaluate the early protection potential of single dose DepoVax/rPA vaccines. A very low dose of rPA that is known to provide partial protection in the rabbit model was used. This allowed a comparison of the potency of the various rPA vaccines formulated in DepoVax.

Rabbits were exposed to a lethal dose of the anthrax causing bacterial spores (B. anthracis) 28 days following a single vaccination. The DepoVax/rPA vaccines provided good protection to animals against anthrax with a single dose, protecting a total of 15 of 24 animals across the three different rPA sources. As expected, control animals injected with a saline solution all succumbed to the anthrax challenge. Animals given a placebo DepoVax vaccine with no antigen also succumbed to anthrax, demonstrating that protection is mediated by the combination of DepoVax and rPA.

Text zur Anzeige gekürzt. Gesamten Beitrag anzeigen »

Bewerten
iwanooze:

beobachten!

 
27.02.15 17:01
Bewerten
Es gibt keine neuen Beiträge.
 Ich: 


Hot-Stocks-Forum - Gesamtforum - Antwort einfügen - zum ersten Beitrag springen

Neueste Beiträge aus dem IMMUNOVACCINE INC Forum

Wertung Antworten Thema Verfasser letzter Verfasser letzter Beitrag
  2 ImmunoVaccine Inc. iwanooze iwanooze 25.04.21 03:27

Foto: - erstellt mit DALL.E, KI-gestützte Bildgenerierung von OpenAI
Wasserstoff Spin-Off + KI-Datencenter NEWS!
weiterlesen»